Eanm/snmmi practice guideline for [f]fdg pet/ct external beam radiotherapy treatment planning in uterine cervical cancer v1.0
Creators
- 1. Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam (Netherlands)
- 2. Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital (Denmark)
- 3. French Military Health Academy, Ecole du Val-de-Grâce, Paris (France)
- 4. Institut de Recherche Biomédicale des Armées, Bretigny-sur-Orge (France)
- 5. Brachytherapy Unit, Gustave Roussy, Villejuif (France)
- 6. Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, San Pedro University Hospital and Centre for Biomedical Research of la Rioja (CIBIR), Logroño (Spain)
- 7. Department of Radiation Oncology, Stanford Cancer Center, CA (United States)
- 8. Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY (United States)
- 9. Joint Department of Medical Imaging, University of Toronto, ON (Canada)
- 10. Department of Nuclear Medicine and Radiation Oncology, Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam (Netherlands)
Description
The aim of this EANM / SNMMI Practice Guideline with ESTRO endorsement is to provide general information and specific considerations about [F]FDG PET/CT in advanced uterine cervical cancer for external beam radiotherapy planning with emphasis on staging and target definition, mostly in FIGO stages IB3-IVA and IVB, treated with curative intention. Guidelines from related fields, relevant literature and leading experts have been consulted during the development of this guideline. As this field is rapidly evolving, this guideline cannot be seen as definitive, nor is it a summary of all existing protocols. Local variations should be taken into consideration when applying this guideline. The background, common clinical indications, qualifications and responsibilities of personnel, procedure / specifications of the examination, documentation / reporting and equipment specifications, quality control and radiation safety in imaging is discussed with an emphasis on the multidisciplinary approach.
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-020-05112-2Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 48
- Journal Issue
- 4
- Journal Page Range
- p. 1188-1199
- ISSN
- 1619-7070
- CODEN
- EJNMA6
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 52059967
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CARCINOMAS; DOCUMENTATION; EXTERNAL BEAM RADIATION THERAPY; FLUORINE 18; FLUORODEOXYGLUCOSE; MEDICAL PERSONNEL; PLANNING; POSITRON COMPUTED TOMOGRAPHY; QUALITY CONTROL; RADIATION PROTECTION; RADIOPHARMACEUTICALS; RECOMMENDATIONS; SAFETY; SPECIFICATIONS; UROGENITAL SYSTEM DISEASES; UTERUS
- Descriptors DEC
- ANTIMETABOLITES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; COMPUTERIZED TOMOGRAPHY; CONTROL; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; FEMALE GENITALS; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; MEDICINE; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ODD-ODD NUCLEI; ORGANS; PERSONNEL; RADIOACTIVE MATERIALS; RADIOISOTOPES; RADIOLOGY; RADIOTHERAPY; THERAPY; TOMOGRAPHY